Cargando…

A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike

The current pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights an urgent need to develop a safe, efficacious, and durable vaccine. Using a measles virus (rMeV) vaccine strain as the backbone, we developed a series of recombinant attenuated vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Mijia, Dravid, Piyush, Zhang, Yuexiu, Trivedi, Sheetal, Li, Anzhong, Harder, Olivia, KC, Mahesh, Chaiwatpongsakorn, Supranee, Zani, Ashley, Kenney, Adam, Zeng, Cong, Cai, Chuanxi, Ye, Chengjin, Liang, Xueya, Shimamura, Masako, Liu, Shan-Lu, Mejias, Asuncion, Ramilo, Octavio, Boyaka, Prosper N., Qiu, Jianming, Martinez-Sobrido, Luis, Yount, Jacob S., Peeples, Mark E., Kapoor, Amit, Niewiesk, Stefan, Li, Jianrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000430/ https://www.ncbi.nlm.nih.gov/pubmed/33688034 http://dx.doi.org/10.1073/pnas.2026153118

Ejemplares similares

SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
por: Lu, Mijia, et al.
Publicado: (2022)

A Methyltransferase-Defective Vesicular Stomatitis Virus-Based SARS-CoV-2 Vaccine Candidate Provides Complete Protection against SARS-CoV-2 Infection in Hamsters
por: Lu, Mijia, et al.
Publicado: (2021)

A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike
por: Zhang, Yuexiu, et al.
Publicado: (2022)

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern
por: Xu, Jiayu, et al.
Publicado: (2023)

Viral N(6)-methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus
por: Xue, Miaoge, et al.
Publicado: (2019)

N(6)-methyladenosine modification enables viral RNA to escape recognition by RNA sensor RIG-I
por: Lu, Mijia, et al.
Publicado: (2020)

The larger attachment glycoprotein of respiratory syncytial virus produced in primary human bronchial epithelial cultures reduces infectivity for cell lines
por: King, Tiffany, et al.
Publicado: (2021)

Efficient Production of Human Norovirus-Specific IgY in Egg Yolks by Vaccination of Hens with a Recombinant Vesicular Stomatitis Virus Expressing VP1 Protein
por: Zhu, Yang, et al.
Publicado: (2019)

A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein
por: Li, Anzhong, et al.
Publicado: (2018)

Viral RNA N(6)-methyladenosine modification modulates both innate and adaptive immune responses of human respiratory syncytial virus
por: Xue, Miaoge, et al.
Publicado: (2021)

5-methylcytosine (m(5)C) RNA modification controls the innate immune response to virus infection by regulating type I interferons
por: Zhang, Yuexiu, et al.
Publicado: (2022)

79. Mucosal Interferon (IFN) Responses in Infants with Respiratory Syncytial Virus (RSV) Infection to Inform Live Attenuated Vaccine (LAV) Development
por: Taveras, Jeanette, et al.
Publicado: (2019)

Interferon‐induced transmembrane protein 3 (IFITM3) limits lethality of SARS‐CoV‐2 in mice
por: Kenney, Adam D, et al.
Publicado: (2023)

131. The Protective Role of Mucosal Interferons in Infants with Respiratory Syncytial Virus (RSV) Infection
por: Taveras, Jeanette, et al.
Publicado: (2020)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Respiratory Syncytial Virus (RSV)–Specific Antibodies in Pregnant Women and Subsequent Risk of RSV Hospitalization in Young Infants
por: Koivisto, Karoliina, et al.
Publicado: (2021)

Architecture of the SARS coronavirus prefusion spike
por: Beniac, Daniel R, et al.
Publicado: (2006)

2783. Expansion of Monocytic Myeloid-Derived Suppressor Cells in Infants with Severe Respiratory Syncytial Virus (RSV) Infection
por: Bedoya, Santiago Acero, et al.
Publicado: (2019)

1186. Increased Respiratory Syncytial Virus (RSV) Viral Replication Leads to Increased Cytokine Production and Polarized Interferon Response in Infant Mucosal Epithelium
por: Glowinski, Rebecca M, et al.
Publicado: (2021)

Generation of a monoclonal antibody reactive to prefusion myocytes
por: Kurisaki, Tomohiro, et al.
Publicado: (2011)

Transient opening of trimeric prefusion RSV F proteins
por: Gilman, Morgan S. A., et al.
Publicado: (2019)

The prefusion structure of herpes simplex virus glycoprotein B
por: Vollmer, B., et al.
Publicado: (2020)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Prefused lysosomes cluster on autophagosomes regulated by VAMP8
por: Chen, Qixin, et al.
Publicado: (2021)

The importance of viral testing in infants and young children with bronchiolitis()
por: Mejias, Asuncion, et al.
Publicado: (2022)

Monomeric prefusion structure of an extremophile gamete fusogen and stepwise formation of the postfusion trimeric state
por: Feng, Juan, et al.
Publicado: (2022)

Structure and immune recognition of trimeric prefusion HIV-1 Env
por: Pancera, Marie, et al.
Publicado: (2014)

Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV
por: Hastie, Kathryn M., et al.
Publicado: (2016)

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
por: Huo, Jiandong, et al.
Publicado: (2020)

Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers
por: Rutten, Lucy, et al.
Publicado: (2020)

A Lactic Acid Bacteria (LAB)-Based Vaccine Candidate for Human Norovirus
por: Craig, Kelsey, et al.
Publicado: (2019)

Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models
por: Lorenzo, María M., et al.
Publicado: (2023)

Use of a Bacterial Artificial Chromosome to Generate Recombinant SARS-CoV-2 Expressing Robust Levels of Reporter Genes
por: Ye, Chengjin, et al.
Publicado: (2022)

Immunological studies of the embryonic muscle cell surface. Antiserum to the prefusion myoblast
Publicado: (1979)

Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states
por: McReynolds, Susanna, et al.
Publicado: (2009)

Protection of calves by a prefusion-stabilized bovine RSV F vaccine
por: Zhang, Baoshan, et al.
Publicado: (2017)

Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins
por: Hsieh, Ching-Lin, et al.
Publicado: (2022)

Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine
por: O’Donnell, Jake S., et al.
Publicado: (2022)

Soluble prefusion-closed HIV-envelope trimers with glycan-covered bases
por: Olia, Adam S., et al.
Publicado: (2023)

Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant
por: Abraham, Roshini S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gufs01154pmtkkpcalqqq18mqq